glp 1 afib Can GLP-1 receptor agonists help reduce risk? While traditionally used for type 2 diabetes and weight loss, GLP-1 RAs may offer benefits in atrial remodeling and AFib risk reduction. As cardiometabolic GLP-1 Drugs Show Growing Promise

(ASPE) Reducing risk of major adverse cardiovascular events (MACE) in adults with obesity or overweight and established cardiovascular diseasewhen the drug has that indication (e.g

Sex-based analysis of de novo variants in neurodevelopmental disorders

Links to Supporting Research about Berberine

[] Urolithin A accumulated in prostate tissue, according to an intervention trial ( n = 70), which showed that daily pomegranate intake until 4 weeks before radical prostatectomy caused this effect ( P = 0.031), but it had no impact on PSA levels, cell division, tumor development, or prostatic oxidative stress

Uneven Skin Tone People experiencing uneven skin tone may consider Gluta White supplements as part of their routine